2-acetylpyridine 5-[(2-chloroanilino)thiocarbonyl]thiocarbonohydrazone compound and salts thereof
US5021437A · kind A · utility
7Cited by
5References
6Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 26, 1989 |
| Grant date | Jun 4, 1991 |
| Priority date | — |
| Expiry date | Jun 26, 2009 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a novel ribonucleotide reductase inhibitor and new combinations comprising an antiviral compound, such as acyclovir, and a thiocarbonohydrazone ribonucleotide reductase inhibitor for the chemotherapeutic treatment of virus infections, especially viruses of the herpes group.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.